BindingDB logo
myBDB logout

null

SMILES: CN1CCC(CC1)n1cc(cn1)-c1ccc2[nH]nc(C(=O)Nc3ncc(C)s3)c2c1

InChI Key: InChIKey=CDNQBRMCVASTDZ-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 484731   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Glycogen synthase kinase-3 beta


(Homo sapiens (Human))
BDBM484731
PNG
(US10934297, Compound 144)
Show SMILES CN1CCC(CC1)n1cc(cn1)-c1ccc2[nH]nc(C(=O)Nc3ncc(C)s3)c2c1
Show InChI InChI=1S/C21H23N7OS/c1-13-10-22-21(30-13)24-20(29)19-17-9-14(3-4-18(17)25-26-19)15-11-23-28(12-15)16-5-7-27(2)8-6-16/h3-4,9-12,16H,5-8H2,1-2H3,(H,25,26)(H,22,24,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 6.44E+3n/an/an/an/a



Samumed, LLC

US Patent


Assay Description
GSK3β: Each compound is dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-respo...


US Patent US10934297 (2021)

More data for this
Ligand-Target Pair
Dual specificity tyrosine-phosphorylation-regulated kinase 1A


(Homo sapiens (Human))
BDBM484731
PNG
(US10934297, Compound 144)
Show SMILES CN1CCC(CC1)n1cc(cn1)-c1ccc2[nH]nc(C(=O)Nc3ncc(C)s3)c2c1
Show InChI InChI=1S/C21H23N7OS/c1-13-10-22-21(30-13)24-20(29)19-17-9-14(3-4-18(17)25-26-19)15-11-23-28(12-15)16-5-7-27(2)8-6-16/h3-4,9-12,16H,5-8H2,1-2H3,(H,25,26)(H,22,24,29)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 8n/an/an/an/a



Samumed, LLC

US Patent


Assay Description
DYRK1A: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response...


US Patent US10934297 (2021)

More data for this
Ligand-Target Pair